Articles by Michael Fronstin - Pharmaceutical Executive


Articles by Michael Fronstin

A Fresh Look at Co-morbidity

You may think you understand a disease. But then it arrives in tandem. A new survey takes a fresh look at co-morbidity.
Jan 1, 2006

As americans age, they are likely to suffer from more than one chronic condition at a time. So as the country's population grays, the rate at which patients presenting co-morbid indications will increase, as will the absolute number of patients whose treatment must be adjusted for more than one disease. These are not surprising facts, but they deserve careful consideration by pharma manufacturers and marketers.


Click here